Pluvicto BPA call CY24 doses

Ended Awarded Last action

Contract number
36C25224N0224
Awardee
Awarding agency
Obligated
$977,750

Award facts

Contract value 100% obligated
$977,749.98 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Millburn, NJ 07041, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 -$710,290
Original award $1,688,040

About this award

This is a Blanket Purchase Agreement (BPA) call order awarded by the Department of Veterans Affairs (VA) to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis and a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract, with a ceiling value of $977,749.98, is for the delivery of PLUVICTO doses in Calendar Year 2024. This order falls under the parent GSA Schedule 61-IB, Pharmaceuticals and Drugs, and is priced on a Firm Fixed Price basis. The contract has no set-aside designation and is expected to be completed by December 31, 2024. Advanced Accelerator Applications USA Inc. has held several significant Indefinite Delivery Vehicles (IDVs) and BPAs with the VA and other federal agencies, primarily for the procurement of specialized radiopharmaceuticals used in cancer treatment and diagnostic imaging applications across the VA healthcare system and other federal facilities.

Quick answers

Who was awarded contract 36C25224N0224?

36C25224N0224 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on January 2, 2024.

How much is contract 36C25224N0224 worth?

The government has obligated $977,750 on 36C25224N0224.

Is contract 36C25224N0224 an order under another contract?

Yes. 36C25224N0224 is a BPA call under 36F79719D0169-36C25223A0017, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25224N0224 competed?

The extent of competition for 36C25224N0224 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award